These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 17852435)

  • 1. Predictive factors of septic shock and mortality in neutropenic patients.
    Ramzi J; Mohamed Z; Yosr B; Karima K; Raihane B; Lamia A; Hela BA; Zaher B; Balkis M
    Hematology; 2007 Dec; 12(6):543-8. PubMed ID: 17852435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with severe sepsis: prospective study of 94 neutropenic febrile episodes.
    Jeddi R; Achour M; Amor RB; Aissaoui L; Bouterâa W; Kacem K; Lakhal RB; Abid HB; BelHadjAli Z; Turki A; Meddeb B
    Hematology; 2010 Feb; 15(1):28-32. PubMed ID: 20132659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors of septic shock in patients with hematologic malignancies and Pseudomonas infections.
    Jeddi R; Ghédira H; Ben Amor R; Turki A; Kacem K; Ben Abdennebi Y; Ben Lakhal R; Aissaoui L; Ben Abid H; Bel Hadjali Z; Meddeb B
    Hematology; 2011 May; 16(3):160-5. PubMed ID: 21669056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Causative pathogens of fever in neutropenic patients at King Chulalongkorn Memorial Hospital.
    Roongpoovapatr P; Suankratay C
    J Med Assoc Thai; 2010 Jul; 93(7):776-83. PubMed ID: 20649055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk index for predicting complications and prognosis in Thai patients with neutropenia and fever.
    Chayakulkeeree M; Thamlikitkul V
    J Med Assoc Thai; 2003 Mar; 86(3):212-23. PubMed ID: 12757060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival in neutropenic patients with severe sepsis or septic shock.
    Legrand M; Max A; Peigne V; Mariotte E; Canet E; Debrumetz A; Lemiale V; Seguin A; Darmon M; Schlemmer B; Azoulay E
    Crit Care Med; 2012 Jan; 40(1):43-9. PubMed ID: 21926615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.
    Moghnieh R; Estaitieh N; Mugharbil A; Jisr T; Abdallah DI; Ziade F; Sinno L; Ibrahim A
    Front Cell Infect Microbiol; 2015; 5():11. PubMed ID: 25729741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Piperacillin/tazobactam plus amikacin versus carbapenem monotherapy as empirical treatment of febrile neutropenia in childhood hematological malignancies.
    Yildirim I; Aytac S; Ceyhan M; Cetin M; Tuncer M; Cengiz AB; Secmeer G; Yetgin S
    Pediatr Hematol Oncol; 2008 Jun; 25(4):291-9. PubMed ID: 18484473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The diagnostic value of C-reactive protein, interleukin-8, and monocyte chemotactic protein in risk stratification of febrile neutropenic children with hematologic malignancies.
    El-Maghraby SM; Moneer MM; Ismail MM; Shalaby LM; El-Mahallawy HA
    J Pediatr Hematol Oncol; 2007 Mar; 29(3):131-6. PubMed ID: 17356388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacteremia and septic shock after solid-organ transplantation.
    Candel FJ; Grima E; Matesanz M; Cervera C; Soto G; Almela M; Martínez JA; Navasa M; Cofán F; Ricart MJ; Pérez-Villa F; Moreno A
    Transplant Proc; 2005 Nov; 37(9):4097-9. PubMed ID: 16386636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Empirical Antibiotic Regimens on Mortality in Neutropenic Patients with Bloodstream Infection Presenting with Septic Shock.
    Chumbita M; Puerta-Alcalde P; Gudiol C; Garcia-Pouton N; Laporte-Amargós J; Ladino A; Albasanz-Puig A; Helguera C; Bergas A; Grafia I; Sastre E; Suárez-Lledó M; Durà X; Jordán C; Marco F; Condom M; Castro P; Martínez JA; Mensa J; Soriano A; Carratalà J; Garcia-Vidal C
    Antimicrob Agents Chemother; 2022 Feb; 66(2):e0174421. PubMed ID: 34843387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of predictors of adverse outcome in febrile neutropenic episodes in pediatric oncology patients.
    Bothra M; Seth R; Kapil A; Dwivedi SN; Bhatnagar S; Xess I
    Indian J Pediatr; 2013 Apr; 80(4):297-302. PubMed ID: 23255077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health-care associated bacteremia in geriatric cancer patients with febrile neutropenia.
    Aydemir H; Piskin N; Kokturk F; Gökmen A; Akduman D
    J Geriatr Oncol; 2013 Apr; 4(2):190-5. PubMed ID: 24071544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features and risk factors for mortality in Aeromonas bacteremic adults with hematologic malignancies.
    Tsai MS; Kuo CY; Wang MC; Wu HC; Chien CC; Liu JW
    J Microbiol Immunol Infect; 2006 Apr; 39(2):150-4. PubMed ID: 16604248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An analysis of interleukin-8, interleukin-6 and C-reactive protein serum concentrations to predict fever, gram-negative bacteremia and complicated infection in neutropenic cancer patients.
    Engel A; Mack E; Kern P; Kern WV
    Infection; 1998; 26(4):213-21. PubMed ID: 9717678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Escherichia coli and Klebsiella pneumoniae bacteremia in patients with neutropenic fever: factors associated with extended-spectrum β-lactamase production and its impact on outcome.
    Kim SH; Kwon JC; Choi SM; Lee DG; Park SH; Choi JH; Yoo JH; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS
    Ann Hematol; 2013 Apr; 92(4):533-41. PubMed ID: 23161391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High pentraxin 3 level predicts septic shock and bacteremia at the onset of febrile neutropenia after intensive chemotherapy of hematologic patients.
    Vänskä M; Koivula I; Hämäläinen S; Pulkki K; Nousiainen T; Jantunen E; Juutilainen A
    Haematologica; 2011 Sep; 96(9):1385-9. PubMed ID: 21880642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between mortality and microbiological parameters in febrile neutropenic patients with hematological malignancies.
    Calik S; Ari A; Bilgir O; Cetintepe T; Yis R; Sonmez U; Tosun S
    Saudi Med J; 2018 Sep; 39(9):878-885. PubMed ID: 30251730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of cefepime + netilmicin or ceftazidime + amikacin or meropenem monotherapy in febrile neutropenic children with malignancy in Turkey.
    Agaoglu L; Devecioglu O; Anak S; Karakas Z; Yalman N; Biner B; Eryilmaz E; Goksan B; Unuvar A; Agirbasli H; Can M; Bilgen H; Gedikoglu G
    J Chemother; 2001 Jun; 13(3):281-7. PubMed ID: 11450887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk index score for bacteremia in febrile neutropenic episodes in children with malignancies.
    Spasova MI; Grudeva-Popova JG; Kostyanev SS; Genev ED; Stoyanova AA; Kirina VI; Moumdjiev IN
    J BUON; 2009; 14(3):411-8. PubMed ID: 19810131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.